Interleukin 22 serum levels are associated with radiographic progression in rheumatoid arthritis
Authors:
- Markus A SchrammMSMarkus A Schramm
- Mathias GrunkeMGMathias Grunke
- Michael BaeuerleMBMichael Baeuerle
- Claudia DechantCDClaudia Dechant
- Axel P NiggANAxel P Nigg
- Matthias N WittMWMatthias N Witt
- Volker VielhauerVVVolker Vielhauer
- Christiane S ReindlCRChristiane S Reindl
- Hendrik Schulze-KoopsHSHendrik Schulze-Koops
- Alla SkapenkoASAlla Skapenko
- 1 August 2011
- journal article
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 70 (8) , 1453-1457
Abstract
Objectives To study the role of interleukin 22 (IL-22) in rheumatoid arthritis (RA). Methods IL-22 serum levels were measured in patients with early, treatment-naive RA (n=49) and in 45 age- and sex-matched healthy individuals as controls. Patients were assessed clinically and radiographically at baseline and followed up for 2 years. Correlations of IL-22 serum levels were sought with parameters of disease activity, serological markers, demographic factors and the incidence of erosions. IL-22 production by peripheral blood T cells was investigated by intracellular flow cytometry. Results 24 of 49 patients with RA demonstrated elevated IL-22 levels compared with the range of healthy controls. At baseline, a high percentage of these patients (8/24, 33%) demonstrated bone erosions, whereas only one patient (4%) from the group with normal IL-22 had erosions. During the 2 years of follow-up, six additional patients with increased IL-22 at baseline developed erosions. In contrast, none of the patients in whom IL-22 levels were normal developed erosions despite similar treatment regimens. Multivariate regression analysis accounting for other parameters predictive for erosions, such as the presence of rheumatoid factor or anti-cyclic citrullinated peptide antibodies and disease activity, showed that elevated IL-22 baseline levels were independently and significantly associated with erosive RA. Cellular analysis demonstrated enhanced expression of IL-22 from CD4 T cells in RA. Conclusion IL-22 is elevated in the serum of half of the patients with RA. Elevated serum IL-22 allows discrimination between patients with different radiographic progression and indicates a possible involvement of IL-22 in the pathophysiology of RA.Keywords
This publication has 22 references indexed in Scilit:
- IL-17 and IL-22: siblings, not twinsTrends in Immunology, 2010
- Role of Th17 cells in human autoimmune arthritisArthritis & Rheumatism, 2010
- Th17 cytokines and arthritisSeminars in Immunopathology, 2010
- 1,25‐dihydroxyvitamin D3 modulates Th17 polarization and interleukin‐22 expression by memory T cells from patients with early rheumatoid arthritisArthritis & Rheumatism, 2009
- Frequency and phenotype of peripheral blood Th17 cells in ankylosing spondylitis and rheumatoid arthritisArthritis & Rheumatism, 2009
- Proinflammatory role of the Th17 cytokine interleukin‐22 in collagen‐induced arthritis in C57BL/6 miceArthritis & Rheumatism, 2009
- Interleukin‐17–producing T cells are enriched in the joints of children with arthritis, but have a reciprocal relationship to regulatory T cell numbersArthritis & Rheumatism, 2008
- IL‐22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasisEuropean Journal of Immunology, 2006
- Expression of interleukin‐22 in rheumatoid arthritis: Potential role as a proinflammatory cytokineArthritis & Rheumatism, 2005
- The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritisArthritis & Rheumatism, 1988